True Wealth Design’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.69K Sell
108
-128
-54% -$3K ﹤0.01% 1569
2026
Q1
$3.31K Hold
236
﹤0.01% 1365
2025
Q4
$2.65K Sell
236
-485
-67% -$5.55K ﹤0.01% 1349
2025
Q3
$8.34K Buy
721
+221
+44% +$2.59K ﹤0.01% 897
2025
Q2
$6.12K Buy
+500
New +$6.29K ﹤0.01% 735
2024
Q4
Sell
-15
Closed -$361 1371
2024
Q3
$361 Buy
+15
New +$343 ﹤0.01% 1139

Other funds holding AVNS

True Wealth Design's AVNS Position: Q2 2026 in Review

True Wealth Design reduced its Avanos Medical (AVNS) stake by 54% in Q2 2026, selling an estimated $3K and leaving 108 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

True Wealth Design first reported a position in AVNS in Q3 2024 and has held it in 6 quarters since. The position peaked at $8.34K in Q3 2025. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • True Wealth Design held 108 shares of Avanos Medical worth $2.69K as of Q2 2026.
  • True Wealth Design sold 128 Avanos Medical shares in Q2 2026, an estimated $3K.
  • Avanos Medical made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1569 holding.
  • True Wealth Design first reported a position in Avanos Medical in Q3 2024 and has held it in 6 quarters since.
  • True Wealth Design's Avanos Medical position peaked at $8.34K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.